-

12:14:27 AM

XXII Stock News

XXII - 22nd Century Group Inc

04/14/22 8:00 AM

Nasdaq : XXII

22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022

22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, will host a live webcast on

RHEA-AI

neutral

04/13/22 8:00 AM

Nasdaq : XXII

First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland

The first and only combustible tobacco cigarette containing minimal to non-addictive

RHEA-AI

neutral

04/11/22 9:25 AM

Nasdaq : XXII

management

22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer

22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving

RHEA-AI

positive

03/28/22 9:28 AM

Nasdaq : XXII

FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing

22nd Century Group, Inc. (Nasdaq: XXII), today announced that it has received notification from the Office of the Illinois Attorney General’s Tobacco Enforcement Bureau that its VLN ® cigarettes will be listed in the Illinois Directory of

RHEA-AI

neutral

03/09/22 9:30 AM

Nasdaq : XXII

conferences

22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15

22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health

RHEA-AI

neutral

03/01/22 6:00 AM

Nasdaq : XXII

earnings

22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021

Secured FDA MRTP Authorization for VLN® King and VLN® Menthol King Reduced Nicotine Content Cigarettes Advancing to U.S. Pilot Market Launch in Chicago Announced Circle K as First VLN® Retail Trade Partner Announced South Korea as the First International VLN® Launch Commenced Hemp/Cannabis Revenue

RHEA-AI

neutral

02/28/22 10:05 AM

Nasdaq : XXII

22nd Century Group Announces South Korea as First VLN® International Market

22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health

RHEA-AI

neutral

02/25/22 9:51 AM

Nasdaq : XXII

22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in Combustible Cigarettes

FDA’s Rulemaking Process Could Make VLN ® Menthol King Reduced Nicotine Cigarettes the Only Menthol Cigarette on the Market Opportunity to Accelerate FDA’s Plan to Cap Nicotine in Cigarettes at Levels Already Achieved in 22nd Century’s VLN ® Products BUFFALO, N.Y., Feb. 25, 2022

RHEA-AI

neutral

02/23/22 8:00 AM

Nasdaq : XXII

22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation

22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine

RHEA-AI

positive

02/10/22 11:30 AM

Nasdaq : XXII

22nd Century Secures USDA Organic Certification for Needle Rock Farms

22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through

RHEA-AI

positive

Prev 1 2 3 4 5 6 7 8 9 10 Next